Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Zhejiang Huahai Pharmaceutical Co. Ltd. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners. This suggests that the company's current patent matters are being reviewed independently.
ROMERO, KRISTEN WANG is the busiest examiner for this portfolio, overseeing 1 pending office action. Since the prosecution also involves distinct art units, the company must manage two separate examination tracks within the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROMERO, KRISTEN WANG | 1 | 69.8% | +30.8% |
| ARCORIA, PAUL JOSEPH | 1 | 100.0% | +0.0% |
| BAHTA, MEDHANIT W | 1 | 80.6% | +27.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18850001 | METHOD FOR PURIFYING LEVETIRACETAM INTERMEDIATE | ARCORIA, PAUL JOSEPH | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18864955 | METHOD FOR PREPARING GLUCOPYRANOSYL-CONTAINING COMPOUND | ROMERO, KRISTEN WANG | — |
| 18704653 | Method for Purifying Pregabalin | BAHTA, MEDHANIT W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18864955 | METHOD FOR PREPARING GLUCOPYRANOSYL-CONTAINING COMPOUND | ROMERO, KRISTEN WANG | — |
| 18704653 | Method for Purifying Pregabalin | BAHTA, MEDHANIT W | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| 1621 | 1 |
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18864955 | METHOD FOR PREPARING GLUCOPYRANOSYL-CONTAINING COMPOUND | ROMERO, KRISTEN WANG | 1624 | §102§103 | Non-Final OA | — | Pending | Nov 12, 2024 |
| 18850001 | METHOD FOR PURIFYING LEVETIRACETAM INTERMEDIATE | ARCORIA, PAUL JOSEPH | 1621 | §103 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18704653 | Method for Purifying Pregabalin | BAHTA, MEDHANIT W | 1692 | §103§112 | Non-Final OA | — | Pending | Apr 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialZhejiang Huahai Pharmaceutical Co. Ltd. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Kristen Wang Romero has the most, with 1 of Zhejiang Huahai Pharmaceutical Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
